Clinical trial · Observational
Prospective Registration Study of Robtic Laparoscopy Versus Laparoscopy Assisted Colon Cancer Surgery
NCT04843189CI-TRIAL-00051227STARS-CC02unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to compare the clinical data of patients with colon cancer who received robotic or laparoscopic surgery, and to compare the short-term and long-term effects of robotic surgery in the treatment of colon cancer. To verify the safety and effectiveness of the corresponding surgical methods, and provide better guidance for the following clinical practice.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colon Cancer | Malignant Colon Neoplasm | CURATED_EXACT | 0.92 |
| Da Vinci Robot | — | UNRESOLVED | — |
| Surgery | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Da Vinci Robotic Surgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Da Vinci Robotic Surgery Group
- description
- Da Vinci Robotic Surgery Group
- interventionNames
- Procedure: Da Vinci Robotic Surgery
- label
- Laparoscopy-assisted surgery group
- description
- Laparoscopy-assisted surgery group
- interventionNames
- Procedure: Da Vinci Robotic Surgery
Primary outcomes (1)
- measure
- Number of lymph nodes harvested
- timeFrame
- During the operation
- description
- Number of lymph nodes harvested
Secondary outcomes (7)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. Age: 18-80 years old, male or female; 2. Colon cancer (ascending colon, transverse colon, descending colon, sigmoid colon) is diagnosed by histology or cytology; 3. The clinical stage is T1-4aN0-2M0; 4 No multiple distant metastases; 5\. ECOG score 0-2; 6. Heart, lung, liver, and kidney functions can tolerate surgery; 7. Patients and their families can understand and are willing to participate in this clinical study, and sign an informed consent. Exclusion Criteria: 1. Past history of malignant colorectal tumors or recent diagnosis combined with other malignant tumors; 2. Patients with intestinal obstruction, intestinal perforation, intestinal bleeding, etc. who need emergency surgery; 3. Neighboring organs need to be combined with organ resection; 4. New adjuvant therapy before surgery; 5. ASA grade ≥ grade IV and/or ECOG physical status score\> 2 points; 6. Those who have severe liver and kidney function, cardiopulmonary function, blood coagulation dysfunction, or combined with serious underlying diseases that cannot tolerate surgery; 7. Have a history of severe mental illness; 8. Pregnant or lactating women; 9. Patients with other clinical and laboratory conditions considered by the investigator should not participate in the trial.
References
Publications (0)
Data not yet available
No reference posted for this study.